SITC Resource Library

One cannot help but feel scared and overwhelmed after receiving a melanoma diagnosis. The challenges that patients, caregivers, family members, and friends face can be daunting and can continue even after treatment has ended.

Beginning in 2010, AIM at Melanoma began partnering with nationally renowned cancer centers across the United States to provide patient-friendly information on new developments, innovative advances in melanoma treatment options, and emerging therapies.  These symposiums also address the many unmet physical, emotional, and psychological needs of those who are touched by this disease.

Listed below are all the Living with Melanoma Symposiums from 2016. You can click on the location of the symposium to view all the videos from that symposium or click on the specific videos pertaining to melanoma immunotherapy.

• January 30, 2016 – Tampa, FL
  • "Understanding Immunotherapy for Metastatic Melanoma – Which Drugs First and When?"
• February 6, 2016 – Columbus, OH
• April 9, 2016 – Pittsburgh, PA
  • "Immunotherapy of Melanoma Targeting PD-1 and Other Inhibitory Receptors"
• May 21, 2016 – Morristown, NJ
• May 21, 2016 – Los Angeles, CA
  • "Current Overview of PD-1 Immunotherapy and Predictive Markers"
  • "Adoptive T cell Therapy for Metastatic Melanoma"
  • "The Next Frontier – New Checkpoint Pathways & Novel Therapies"
• September 22, 2016 – New Haven, CT – Part I – Part II
• September 24, 2016 – New Rochelle, NY
  • "Immunotherapy in Melanoma"
• September 24, 2016 – Memphis, TN
• September 29, 2016 – Chicago, IL
• October 1, 2016 – Salt Lake City, UT

To view more information about the Living with Melanoma Symposiums and more AIM at Melanoma resources please click here.

To view additional past Living with Melanoma Symposium videos please click on the year you wish to view: 2015, 2017, 2018, 2019

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.

#Biomarkers#ClinicalTrials#Tcells#Melanoma#InPersonEvent#Video#WebPage
#CollaborativePartner#AdverseEvents#SideEffects#AdoptiveCellTherapy
#CombinationTherapy#ImmuneCheckpointInhibitors#Ipilimumab#Nivolumab
#Pembrolizumab#AIMatMelanoma#Patient#PatientAdvocate#2016
#Immunomodulators